| 注册
首页|期刊导航|中医学报|中医药影响芳香烃受体介导慢性肾脏病肾纤维化

中医药影响芳香烃受体介导慢性肾脏病肾纤维化

田力臻 王雨典 张薇 王娟 胡安澜 于小勇

中医学报2025,Vol.40Issue(5):1032-1038,7.
中医学报2025,Vol.40Issue(5):1032-1038,7.DOI:10.16368/j.issn.1674-8999.2025.05.167

中医药影响芳香烃受体介导慢性肾脏病肾纤维化

Traditional Chinese Medicine Influencing Aromatic Hydrocarbon Receptor-Mediated Renal Fibrosis in Chronic Kidney Disease

田力臻 1王雨典 1张薇 1王娟 1胡安澜 1于小勇2

作者信息

  • 1. 陕西中医药大学,陕西 咸阳 712046
  • 2. 陕西省中医医院,陕西 西安 710003
  • 折叠

摘要

Abstract

Renal fibrosis is a global health problem and a major pathological outcome of various chronic kidney diseases progressing to end-stage renal disease.Multiple signaling pathways regulate the progression of renal fibrosis,and so far there is still a lack of effective methods to inhibit or even reverse its progression.The aryl hydrocarbon receptor(AhR)is a ligand-activated transcription factor that mediates the toxicological effects of a variety of endogenous substance metabolites and exogenous toxicants.Studies have shown that AhR is widely expressed in many types of cells and is involved in a variety of biological processes,playing an important role in renal fibrosis.Traditional Chinese medicine can inhibit renal tissue injury in chronic kidney disease by regulating the AhR signaling pathway,improve the progression of renal fibrosis and disease prognosis,and enhance patients′living standards.

关键词

芳香烃受体/慢性肾脏病/肾纤维化

Key words

aromatic hydrocarbon receptor/chronic kidney disease/renal fibrosis

分类

医药卫生

引用本文复制引用

田力臻,王雨典,张薇,王娟,胡安澜,于小勇..中医药影响芳香烃受体介导慢性肾脏病肾纤维化[J].中医学报,2025,40(5):1032-1038,7.

基金项目

国家自然科学基金项目(82174366) (82174366)

中医学报

1674-8999

访问量0
|
下载量0
段落导航相关论文